The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Admission of Shares

12 Nov 2020 07:00

RNS Number : 0335F
ProPhotonix Limited
12 November 2020
 

 

November 12, 2020

 

ProPhotonix Limited

 

("ProPhotonix" or the "Group")

 

Admission of Shares

 

ProPhotonix Limited, (London Stock Exchange - (AIM: PPIX, OTC: STKR), a high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the United Kingdom, announces that further to the announcement of 9 November 2020, the Company confirms that the 150,000 Common Shares set out in that announcement will commence trading on AIM ("Admission") tomorrow, 13 November 2020.

Following Admission, the Company's issued share capital will comprise 93,300,402 common shares with voting rights. The Company does not hold any common shares in treasury. Therefore, the total number of common shares in the Company with voting rights will be 93,300,402. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

Enquiries:

 

ProPhotonix Limited Tel: +1 603 893 8778

Tim Losik, President and CEO Email: ir@prophotonix.com

 

WH Ireland Limited

(Nominated Adviser and Broker)

Katy Mitchell

Matthew Chan

 

 

Tel: +44 (0)207 894 7000

 

About ProPhotonix

 

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of LED illumination systems and laser diode modules for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio, Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FUREAKFFFAAEFFA

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.